GAB
CVS icon

German American Bancorp’s CVS Health CVS Stock Holding History

German American Bancorp’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Sell
4,048
-927
-19% -$82.7K 0.03% 109
2026
Q1 		$357K Buy
+4,975
New +$383K 0.03% 109
2024
Q2 		– Sell
-54,823
Closed -$4.37M – 128
2024
Q1 		$4.37M Buy
54,823
+7,954
+17% +$608K 0.53% 44
2023
Q4 		$3.7M Sell
46,869
-8,880
-16% -$632K 0.49% 45
2023
Q3 		$3.89M Buy
55,749
+1,016
+2% +$72K 0.57% 44
2023
Q2 		$3.78M Buy
54,733
+409
+0.8% +$29.1K 0.53% 44
2023
Q1 		$4.04M Sell
54,324
-1,828
-3% -$153K 0.6% 43
2022
Q4 		$5.23M Buy
56,152
+174
+0.3% +$16.8K 0.83% 35
2022
Q3 		$5.34M Buy
55,978
+1,325
+2% +$131K 0.93% 29
2022
Q2 		$5.06M Sell
54,653
-2,458
-4% -$240K 0.85% 26
2022
Q1 		$5.78M Buy
57,111
+140
+0.2% +$14.7K 0.84% 33
2021
Q4 		$5.88M Buy
56,971
+1,139
+2% +$105K 0.82% 35
2021
Q3 		$4.74M Buy
55,832
+2,572
+5% +$215K 0.73% 37
2021
Q2 		$4.44M Buy
53,260
+2,471
+5% +$202K 0.7% 38
2021
Q1 		$3.82M Buy
50,789
+4,156
+9% +$303K 0.66% 40
2020
Q4 		$3.19M Buy
46,633
+2,817
+6% +$183K 0.63% 39
2020
Q3 		$2.56M Buy
43,816
+561
+1% +$34.9K 0.63% 39
2020
Q2 		$2.81M Buy
43,255
+1,198
+3% +$75.4K 0.74% 38
2020
Q1 		$2.5M Buy
42,057
+11,989
+40% +$800K 0.74% 40
2019
Q4 		$2.23M Sell
30,068
-10,094
-25% -$709K 0.55% 45
2019
Q3 		$2.53M Buy
40,162
+682
+2% +$40.4K 0.67% 43
2019
Q2 		$2.15M Buy
39,480
+2,075
+6% +$112K 0.59% 44
2019
Q1 		$2.02M Buy
37,405
+1,174
+3% +$72.5K 0.6% 45
2018
Q4 		$2.37M Buy
36,231
+698
+2% +$52.1K 0.79% 38
2018
Q3 		$2.8M Sell
35,533
-266
-0.7% -$19K 0.84% 36
2018
Q2 		$2.3M Buy
+35,799
New +$2.36M 0.72% 41

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

German American Bancorp's CVS Position: Q2 2026 in Review

German American Bancorp reduced its CVS Health (CVS) stake by 19% in Q2 2026, selling an estimated $82.7K and leaving 4,048 shares worth $419K. The position accounts for 0.03% of the portfolio, ranked #109.

German American Bancorp first reported a position in CVS in Q2 2018 and has held it in 26 quarters since. The position peaked at $5.88M in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • German American Bancorp held 4,048 shares of CVS Health worth $419K as of Q2 2026.
  • German American Bancorp sold 927 CVS Health shares in Q2 2026, an estimated $82.7K.
  • CVS Health made up 0.03% of German American Bancorp's portfolio in Q2 2026, its #109 holding.
  • German American Bancorp first reported a position in CVS Health in Q2 2018 and has held it in 26 quarters since.
  • German American Bancorp's CVS Health position peaked at $5.88M in Q4 2021.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on German American Bancorp's 13F filing for Q2 2026, filed 6 Aug 2026.